Public Company News

Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program

- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...

2021-10-20 05:08 2454

China Liberal Announces Results of Annual General Meeting of Shareholders for Fiscal Year 2021

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", the "Company", or "we"), a China-based company that provides smart campus solutions and other educational services, today announced the results of the Company's 2021 Annual General Mee...

2021-10-19 21:00 1915

E-Home Household Service Holdings Limited Dissolves the VIE Structure

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that its indirectly wholly owned Chinese subsidiary, E-Home Household Service Technology Co., Ltd....

2021-10-19 20:30 3849

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...

2021-10-19 20:00 2112

Pingtan Marine Enterprise Receives Nasdaq's Determination Letter

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan," or the "Company"), a fishing company based in the People's Republic of China, announced today that it received a determination notice letter datedOctober 13, 2021 (the "Determination Notice") fr...

2021-10-19 20:00 4261

Zenix Enters into Definitive Agreement for "Going Private" Transaction

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Zenix Auto International Limited (OTC: ZXAIY) (the "Company"), one of the largest commercial vehicle wheel manufacturers inChina in both the aftermarket and OEM market by sales volume, today announced that it has entered into an Agreement and Plan of M...

2021-10-19 19:33 4174

36Kr Announces Short-Form Video Marketing Collaboration with Intel

BEIJING, Oct. 19, 2021 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants inChina, today announced that the Company has provided customized short-form video advertising solutions for ...

2021-10-19 19:00 2187

Carrier Acquires Cavius, an Innovative Residential Alarm Company

Strategic acquisition expands Carrier's Healthy Homes offering and strengthens its interconnected Fire & Security portfolio PALM BEACH GARDENS, Fla., Oct. 19, 2021 /PRNewswire/ -- Carrier Global Corporation (NYSE:CARR) the leading global provider of healthy, safe, sustainable and intelligent bui...

2021-10-19 18:55 4355

Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...

2021-10-19 17:52 2530

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in theAsia Pacific region, under lice...

2021-10-19 15:01 2375

Tingo, Inc. Announces Submission of Listing Application to the New York Stock Exchange

Company Seeks to Enhance Profile and Investor Reach NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Tingo, Inc., OTC Markets (IWBB) ("Tingo" or the "Company") announced today that it has submitted an application to list its shares for trading with the New York Stock Exchange (NYSE). The application to t...

2021-10-19 14:25 3129

InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China

BEIJING, Oct. 19, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for itsSHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189, which is the company's...

2021-10-19 12:56 2357

Shikigaku Co., Ltd. (7049, TSE Mothers) performance for the first six months ended august 31, 2021

TOKYO, Oct. 18, 2021 /PRNewswire/ -- Both sales and profit grew substantially during the six months endedAugust 31, 2021. Results were strong in the core Consulting business, and the Company reported large growth in performance from management consulting services and platform services. Summary o...

2021-10-19 10:10 2315

Huaneng Power International, Inc. Domestic Electricity Sold in the First Three Quarters of 2021 Increased by 17.11% Year-on-Year

BEIJING, Oct. 18, 2021 /PRNewswire/ -- Huaneng Power International, Inc. ("HPI", the "Company") (NYSE: HNP; HKEx: 902; SSE: 600011) today announced its power generation in the first three quarters of 2021. According to the preliminary statistics of Huaneng Power International, Inc., (the "Compan...

2021-10-18 22:58 3144

The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics

SUZHOU, China, and ROCKVILLE, Md., Oct. 18, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a research team led by Prof. Shaomeng Wang, ...

2021-10-18 22:42 8204

Trip.com Group Announces Entry into Facility Agreement

SHANGHAI, Oct. 18, 2021 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, today announced that it...

2021-10-18 20:32 3032

Tantech Subsidiary Drives Sales Momentum with New Order for 15 Midibuses

LISHUI, China, Oct. 18, 2021 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), a clean energy company inChina, today announced that its subsidiary, Shangchi Automobile Co., Ltd., continues to drive sales momentum with its new order for 15 midibuses. Shangchi Autom...

2021-10-18 20:00 2992

I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China

SHANGHAI and GAITHERSBURG, Md., Oct. 18, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China ...

2021-10-18 20:00 2132

iClick Interactive Asia Group Limited Announces Receipt of another Unsolicited Preliminary Non-Binding Indicative Offer to Acquire the Company

HONG KONG, Oct. 18, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform inChina that empowers worldwide brands with full-stack consumer lifecycle solutions, announced today that onOctober 17, 2021...

2021-10-18 20:00 3405

Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications

LISHUI, China, Oct. 18, 2021 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) announced that one of its healthcare subsidiaries, Zhejiang Farmmi Biotechnology Co., Ltd., has been assessed and has been awarded the certificate for compliance with the requirements of  BRC Glob...

2021-10-18 20:00 2226
1 ... 704705706707708709710 ... 766